Histogenics Corporation (HSGX) financial statements (2021 and earlier)

Company profile

Business Address 5 GREAT VALLEY PARKWAY
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24191537153
Cash and cash equivalents24191537153
Assets held-for-sale, not part of disposal group  7777 
Other undisclosed current assets2111110
Total current assets:2620231116233
Noncurrent Assets
Property, plant and equipment100000 
Restricted cash and investments000000 
Other noncurrent assets100110 
Total noncurrent assets:111111 
TOTAL ASSETS:2721241217243
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3333471
Accounts payable0012261
Accrued liabilities3221210
Debt014000 
Other liabilities00000  
Other undisclosed current liabilities000  28 
Total current liabilities:44735351
Noncurrent Liabilities
Long-term debt and lease obligation222211 
Long-term debt, excluding current maturities222211 
Finance lease, liability     0 
Operating lease, liability000000 
Liabilities, other than long-term debt   00 11
Accounts payable and accrued liabilities      0
Contract with customer, liability10
Due to related parties      1
Other liabilities   00  
Other undisclosed noncurrent liabilities (0)(0)    
Total noncurrent liabilities:22221111
Total liabilities:669563712
Stockholders' equity
Stockholders' equity attributable to parent, including:221415711(13)(9)
Common stock2211101
Treasury stock, value(0)(0)(0)(0)(0)  
Additional paid in capital938272626251220
Retained earnings (accumulated deficit)(73)(70)(59)(55)51(64)(229)
Other undisclosed stockholders' equity attributable to parent    (103)  
Total stockholders' equity:221415711(13)(9)
TOTAL LIABILITIES AND EQUITY:2721241217243

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Gross profit:  0    
Operating expenses(4)(10)(3)(4)(4)(3)(3)
Operating loss:(4)(10)(3)(4)(4)(3)(3)
Nonoperating income (expense)0(0)(0)(0)17(20)(0)
Other nonoperating income (expense)0  (0)(0)(1)0
Interest and debt expense(0)(0)(0)(0)(0)(1) 
Income (loss) before gain (loss) on sale of properties:(4)(11)(4)(4)12(24)(3)
Other undisclosed net income0  00  
Net income (loss):(4)(11)(4)(4)12(24)(3)
Other undisclosed net income attributable to parent 00  1 
Net income (loss) attributable to parent:(4)(10)(4)(4)12(23)(3)
Preferred stock dividends and other adjustments  (13)    
Net income (loss) available to common stockholders, diluted:(4)(10)(16)(4)12(23)(3)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(4)(11)(4)(4)12(24)(3)
Comprehensive income (loss):(4)(11)(4)(4)12(24)(3)
Other undisclosed comprehensive income, net of tax, attributable to parent 00  1 
Comprehensive income (loss), net of tax, attributable to parent:(4)(10)(4)(4)12(23)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: